アリール尿素誘導体

Japanese Patent JP2008509982

A

A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.

Jason Broxham
Matthew Colin Thor Fife
James Horsewill
Liberty Perpetual Jevaratnam
John Kylie
Martin James Proctor
Karen Leslie Scofield
Saram Shabang
Simon Andrew Swain
Philip Wong-Kai-In

JP2007526578A

April 03, 2008

August 16, 2005

Click for automatic bibliography generation  

Prosidion Limited

C07D207/335; A61K31/17; A61K31/198; A61K31/245; A61K31/275; A61K31/341; A61K31/343; A61K31/357; A61K31/381; A61K31/40; A61K31/402; A61K31/403; A61K31/415; A61K31/4155; A61K31/4164; A61K31/421; A61K31/426; A61K31/428; A61K31/433; A61K31/44; A61K31/4409; A61K31/444; A61K31/4453; A61K31/472; A61K31/505; A61K31/5375; A61K31/5377; A61K31/55; A61K31/553; A61P1/00; A61P3/00; A61P3/04; A61P5/00; A61P9/00; A61P11/00; A61P15/00; A61P25/02; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/24; A61P25/28; A61P25/32; A61P25/34; A61P25/36; A61P37/02; A61P43/00; C07C275/30; C07C275/34; C07C275/38; C07C275/42; C07D207/325; C07D209/08; C07D213/64; C07D213/74; C07D213/75; C07D213/80; C07D217/04; C07D231/12; C07D231/56; C07D233/61; C07D239/26; C07D239/42; C07D263/32; C07D267/10; C07D277/20; C07D277/46; C07D277/56; C07D277/62; C07D277/64; C07D277/82; C07D285/06; C07D285/08; C07D285/135; C07D295/12; C07D295/18; C07D307/68; C07D307/78; C07D319/18; C07D333/20; C07D333/36; C07D333/38; C07D333/40; C07D333/66; C07D401/04; C07D409/04; C07D409/12

WO2004048319A1

2004-06-10

Kyousei Tamura
Samejima Mutsumi
Masahiro Nitta

Previous Patent: 新生児対象における神経保護剤としてのキセノンの使用

Next Patent: アンドロゲンモジュレーター